Solasia Pharma K.K. (4597.T)

JPY 33.0

(0.0%)

Long Term Debt Summary of Solasia Pharma K.K.

  • Solasia Pharma K.K.'s latest annual long term debt in 2023 was 27 Million JPY , down 0.0% from previous year.
  • Solasia Pharma K.K.'s latest quarterly long term debt in 2024 Q2 was 11 Million JPY , down 0.0% from previous quarter.
  • Solasia Pharma K.K. reported annual long term debt of - JPY in 2022, down -100.0% from previous year.
  • Solasia Pharma K.K. reported annual long term debt of 37 Million JPY in 2021, up 76.19% from previous year.
  • Solasia Pharma K.K. reported quarterly long term debt of 20 Million JPY for 2024 Q1, down 0.0% from previous quarter.
  • Solasia Pharma K.K. reported quarterly long term debt of 27 Million JPY for 2023 Q4, down -25.0% from previous quarter.

Annual Long Term Debt Chart of Solasia Pharma K.K. (2023 - 2013)

Historical Annual Long Term Debt of Solasia Pharma K.K. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 27 Million JPY 0.0%
2022 - JPY -100.0%
2021 37 Million JPY 76.19%
2020 21 Million JPY -22.22%
2019 27 Million JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY -100.0%
2015 2.86 Billion JPY 116.98%
2014 1.32 Billion JPY 165.66%
2013 497.41 Million JPY 0.0%

Peer Long Term Debt Comparison of Solasia Pharma K.K.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 97.807%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.999%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.98%
Shionogi & Co., Ltd. 8.75 Billion JPY 99.692%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 97.656%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.98%
Morishita Jintan Co., Ltd. 106 Million JPY 74.528%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY 64.474%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 99.615%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 99.798%
Tsumura & Co. 54.37 Billion JPY 99.95%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -22.727%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.986%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 99.774%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 99.66%
KYORIN Holdings, Inc. 435 Million JPY 93.793%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 99.015%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 99.422%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Modalis Therapeutics Corporation 412.5 Million JPY 93.455%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 99.401%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.96%
Cyfuse Biomedical K.K. 345 Million JPY 92.174%
Toho Holdings Co., Ltd. 28.16 Billion JPY 99.904%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 98.303%